The Duke Cancer Institute's Biospecimen Repository and Processing Core/Shared Resource (BRPC) is the result of substantially increased institutional support for biobanking at Duke since the last CCSG renewal. The BRPC utilizes the strong infrastructure of the previous CCSG-supported biobanking Shared Resource, the Tissue and Blood Procurement Core, and incorporated its existing collection. However, the BRPC has significant advantages to DCI members because it stems from a concerted institutional and ground-up effort to reinvent and strengthen the resource to better meet biobanking needs across the institution. The BRPC's priority is to maximize tissue available for research while ensuring that sufficient, intact tissue is available for clinical pathologic assessment and reporting. It achieves this by integration with the Department of Pathology, and it functions under the favored honest-broker model of biobanking. BRPC obtains consent and collects tissue for both true excess tissue surgical events as well as additional tissue biopsy events (paired needle core breast biopsies, for example). Governance of biospecimen use is provided separately by the 10 disease-site groups of the DCI (distinct from but overlapping the nine CCSG-identified Research Programs) for relevant biospecimens. Since inception of the facility in 2012, BRPC services have been utilized by 49 Duke faculty, 38 of whom are DCI members. The DCI users represent eight of the nine DCI CCSG-recognized Research Programs. The BRPC operating budget is supported by the DCI (71%) and the Duke School of Medicine (29%) to support the initial growth and development of the BRPC. Year one of operations was completely subsidized (for 600 unique patient biobanking consenting and collection events) in an effort to increase investigator and disease- site working group awareness of the shared resource. In year two and beyond, gradual charge backs have been implemented and satisfied investigators are building the BRPC into their grant and contract applications. The BRPC's immediate objectives are to (1) engage additional user groups from the DCI; (2) prepare for the transition to a new informatics system expected in mid-2014. Our long-term objectives are to formalize a process for true overnight banking across multiple interested parties and to provide DCI members access to Duke's clinical archives of paraffin-embedded biospecimens, in accordance with clinical requirements.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Duke University
United States
Zip Code
Galaz-Montoya, Monica; Wright, Sara J; Rodriguez, Gustavo J et al. (2017) ?2-Adrenergic receptor activation mobilizes intracellular calcium via a non-canonical cAMP-independent signaling pathway. J Biol Chem 292:9967-9974
Lanier, Megan L; Park, Hyeri; Mukherjee, Paramita et al. (2017) Formal Synthesis of (+)-Laurencin by Gold(I)-Catalyzed Intramolecular Dehydrative Alkoxylation. Chemistry 23:7180-7184
Shi, Qiong; Liu, Hongliang; Han, Peng et al. (2017) Genetic Variants in WNT2B and BTRC Predict Melanoma Survival. J Invest Dermatol 137:1749-1756
Woyach, Jennifer A; Ruppert, Amy S; Guinn, Daphne et al. (2017) BTKC481S-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia. J Clin Oncol 35:1437-1443
Wang, Yanru; Freedman, Jennifer A; Liu, Hongliang et al. (2017) Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer. Int J Cancer 141:731-743
Fayanju, Oluwadamilola M; Hall, Carolyn S; Bauldry, Jessica Bowman et al. (2017) Body mass index mediates the prognostic significance of circulating tumor cells in inflammatory breast cancer. Am J Surg 214:666-671
Leu, David; Spasojevic, Ivan; Nguyen, Huy et al. (2017) CNS bioavailability and radiation protection of normal hippocampal neurogenesis by a lipophilic Mn porphyrin-based superoxide dismutase mimic, MnTnBuOE-2-PyP5. Redox Biol 12:864-871
Sauer, Scott J; Tarpley, Michael; Shah, Imran et al. (2017) Bisphenol A activates EGFR and ERK promoting proliferation, tumor spheroid formation and resistance to EGFR pathway inhibition in estrogen receptor-negative inflammatory breast cancer cells. Carcinogenesis 38:252-260
Pan, Yongchu; Liu, Hongliang; Wang, Yanru et al. (2017) Associations between genetic variants in mRNA splicing-related genes and risk of lung cancer: a pathway-based analysis from published GWASs. Sci Rep 7:44634
Yin, Jieyun; Liu, Hongliang; Liu, Zhensheng et al. (2017) Pathway-analysis of published genome-wide association studies of lung cancer: A potential role for the CYP4F3 locus. Mol Carcinog 56:1663-1672

Showing the most recent 10 out of 480 publications